{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:43:25Z","timestamp":1791978205469,"version":"4.4.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24 HD071843"],"award-info":[{"award-number":["K24 HD071843"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK062249\u201310"],"award-info":[{"award-number":["R01 DK062249\u201310"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ghir.2020.101317","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T12:20:03Z","timestamp":1584966003000},"page":"101317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Potential applications for rhIGF-I: Bone disease and IGF I"],"prefix":"10.1016","volume":"52","author":[{"given":"Marisol","family":"Bahamonde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9405-2981","authenticated-orcid":false,"given":"Madhusmita","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ghir.2020.101317_bb0005","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/jbmr.422","article-title":"Concerted actions of insulin-like growth factor 1, testosterone, and estradiol on peripubertal bone growth: a 7-year longitudinal study","volume":"26","author":"Xu","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.ghir.2020.101317_bb0010","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/me.2011-0047","article-title":"Liver-derived IGF-I contributes to GH-dependent increases in lean mass and bone mineral density in mice with comparable levels of circulating GH","volume":"25","author":"Nordstrom","year":"2011","journal-title":"Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.ghir.2020.101317_bb0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/08977194.2013.770392","article-title":"Effects and differentiation activity of IGF-I, IGF-II, insulin and preptin on human primary bone cells","volume":"31","author":"Bosetti","year":"2013","journal-title":"Growth Factors"},{"key":"10.1016\/j.ghir.2020.101317_bb0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ghir.2015.09.004","article-title":"Regulation of skeletal growth and mineral acquisition by the GH\/IGF-1 axis: lessons from mouse models","volume":"28","author":"Yakar","year":"2016","journal-title":"Growth Hormon. IGF Res."},{"issue":"4","key":"10.1016\/j.ghir.2020.101317_bb0025","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/jcb.22322","article-title":"Growth factor control of bone mass","volume":"108","author":"Canalis","year":"2009","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.ghir.2020.101317_bb0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00774-010-0210-3","article-title":"Effects of growth hormone on bone modeling and remodeling in hypophysectomized young female rats: a bone histomorphometric study","volume":"29","author":"Iglesias","year":"2011","journal-title":"J. Bone Miner. Metab."},{"issue":"2","key":"10.1016\/j.ghir.2020.101317_bb0035","doi-asserted-by":"crossref","first-page":"E271","DOI":"10.1152\/ajpendo.00092.2013","article-title":"Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity","volume":"305","author":"Lau","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2020.101317_bb0040","doi-asserted-by":"crossref","first-page":"E1191","DOI":"10.1152\/ajpendo.00440.2011","article-title":"Conditional disruption of IGF-I gene in type 1alpha collagen-expressing cells shows an essential role of IGF-I in skeletal anabolic response to loading","volume":"301","author":"Kesavan","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.ghir.2020.101317_bb0045","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2016-3071","article-title":"The relationship between Calciotropic hormones, IGF-1, and bone mass across pubertal stages","volume":"101","author":"Matar","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2020.101317_bb0050","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1210\/jc.2010-0595","article-title":"25-hydroxyvitamin D, insulin-like growth factor-I, and bone mineral accrual during growth","volume":"96","author":"Breen","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.ghir.2020.101317_bb0055","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/jbmr.234","article-title":"IGF-1 and bone: new discoveries from mouse models","volume":"25","author":"Yakar","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.ghir.2020.101317_bb0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1677\/joe.0.1800247","article-title":"Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth","volume":"180","author":"Wang","year":"2004","journal-title":"J Endocrinol"},{"issue":"6","key":"10.1016\/j.ghir.2020.101317_bb0065","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1172\/JCI0215463","article-title":"Circulating levels of IGF-1 directly regulate bone growth and density","volume":"110","author":"Yakar","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"Suppl. 2","key":"10.1016\/j.ghir.2020.101317_bb0070","first-page":"739","article-title":"Clinical relevance of systemic and local IGF-I: lessons from animal models","volume":"5","author":"LeRoith","year":"2008","journal-title":"Pediatr. Endocrinol. Rev."},{"issue":"3","key":"10.1016\/j.ghir.2020.101317_bb0075","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1096\/fj.08-118976","article-title":"Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism","volume":"23","author":"Yakar","year":"2009","journal-title":"FASEB J."},{"issue":"1\u20132","key":"10.1016\/j.ghir.2020.101317_bb0080","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1385\/ENDO:20:1-2:149","article-title":"Body composition of prolactin-, growth hormone, and thyrotropin-deficient Ames dwarf mice","volume":"20","author":"Heiman","year":"2003","journal-title":"Endocrine"},{"issue":"10","key":"10.1016\/j.ghir.2020.101317_bb0085","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1210\/en.2006-0171","article-title":"Insulin-like growth factor binding protein (IGFBP-1) involvement in intrauterine growth retardation: study on IGFBP-1 overexpressing transgenic mice","volume":"147","author":"Ben Lagha","year":"2006","journal-title":"Endocrinology"},{"issue":"1\u20132","key":"10.1016\/j.ghir.2020.101317_bb0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00429-002-0282-5","article-title":"Insulin-like growth factor-binding protein-2 (IGFBP-2) overexpression negatively regulates bone size and mass, but not density, in the absence and presence of growth hormone\/IGF-I excess in transgenic mice","volume":"206","author":"Eckstein","year":"2002","journal-title":"Anat Embryol (Berl)"},{"issue":"10","key":"10.1016\/j.ghir.2020.101317_bb0095","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1359\/jbmr.2003.18.10.1834","article-title":"Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice","volume":"18","author":"Silha","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.ghir.2020.101317_bb0100","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1210\/en.2004-0816","article-title":"Insulin-like growth factor-binding protein-5 induces a gender-related decrease in bone mineral density in transgenic mice","volume":"146","author":"Salih","year":"2005","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.ghir.2020.101317_bb0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/EJE-18-0711","article-title":"Bone microarchitecture and volumetric bone density impairment in young male adults with childhood-onset growth hormone deficiency","volume":"180","author":"Yang","year":"2019","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.ghir.2020.101317_bb0110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1359\/jbmr.1998.13.3.415","article-title":"Bone mineral, histomorphometry, and body composition in adults with growth hormone receptor deficiency","volume":"13","author":"Bachrach","year":"1998","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.ghir.2020.101317_bb0115","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1365-2265.1996.7990809.x","article-title":"Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome","volume":"45","author":"Klinger","year":"1996","journal-title":"Clin. Endocrinol."},{"issue":"12","key":"10.1016\/j.ghir.2020.101317_bb0120","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1359\/jbmr.2001.16.12.2320","article-title":"The skeletal structure of insulin-like growth factor I-deficient mice","volume":"16","author":"Bikle","year":"2001","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.ghir.2020.101317_bb0125","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1210\/jcem.85.4.6495","article-title":"Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion","volume":"85","author":"Woods","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2020.101317_bb0130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fendo.2017.00227","article-title":"Bone status in a patient with insulin-like growth Factor-1 receptor deletion syndrome: bone quality and structure evaluation using dual-energy X-ray absorptiometry, peripheral quantitative computed tomography, and quantitative ultrasonography","volume":"8","author":"Pelosi","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.ghir.2020.101317_bb0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1677\/JOE-09-0328","article-title":"A novel spontaneous mutation of Irs1 in mice results in hyperinsulinemia, reduced growth, low bone mass and impaired adipogenesis","volume":"204","author":"DeMambro","year":"2010","journal-title":"J. Endocrinol."},{"issue":"3","key":"10.1016\/j.ghir.2020.101317_bb0140","first-page":"212","article-title":"The polymorphism in insulin receptor substrate-1 gene and birth weight in neonates at term","volume":"59","author":"Simonska-Cichocka","year":"2008","journal-title":"Endokrynol Pol"},{"issue":"9","key":"10.1016\/j.ghir.2020.101317_bb0145","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1210\/jc.2001-011889","article-title":"Abnormal bone mineral accrual in adolescent girls with anorexia nervosa","volume":"87","author":"Soyka","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2020.101317_bb0150","first-page":"2049","article-title":"Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea","volume":"84","author":"Grinspoon","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ghir.2020.101317_bb0155","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1210\/jc.2017-01916","article-title":"Increases in IGF-1 after anti-TNF-alpha therapy are associated with bone and muscle accrual in Pediatric Crohn disease","volume":"103","author":"DeBoer","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2020.101317_bb0160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2265.2007.02992.x","article-title":"Changes and relationships of IGFS and IGFBPS and cytokines in coeliac disease at diagnosis and on gluten-free diet","volume":"68","author":"Street","year":"2008","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/j.ghir.2020.101317_bb0165","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/(SICI)1520-7560(199907\/08)15:4<254::AID-DMRR47>3.0.CO;2-F","article-title":"The circulating insulin-like growth factor system in children with coeliac disease: an additional marker for disease activity","volume":"15","author":"Locuratolo","year":"1999","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"4","key":"10.1016\/j.ghir.2020.101317_bb0170","first-page":"162","article-title":"Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines","volume":"66","author":"Street","year":"2006","journal-title":"Horm. Res."},{"issue":"1","key":"10.1016\/j.ghir.2020.101317_bb0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jbmr.3290","article-title":"Reduced serum IGF-1 associated with hepatic osteodystrophy is a main determinant of low cortical but not trabecular bone mass","volume":"33","author":"Liu","year":"2018","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.ghir.2020.101317_bb0180","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s00198-018-4638-y","article-title":"Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus","volume":"29","author":"Kanazawa","year":"2018","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.ghir.2020.101317_bb0185","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1677\/joe.0.1590297","article-title":"Serum levels of insulin-like growth factor system components and relationship to bone metabolism in type 1 and type 2 diabetes mellitus patients","volume":"159","author":"Jehle","year":"1998","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ghir.2020.101317_bb0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ghir.2017.04.003","article-title":"Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH\/IGF-1 axis","volume":"34","author":"Raisingani","year":"2017","journal-title":"Growth Hormon. IGF Res."},{"issue":"4","key":"10.1016\/j.ghir.2020.101317_bb0195","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00381-017-3346-9","article-title":"Bone mineral density and insulin-like growth factor-1 in children with spastic cerebral palsy","volume":"33","author":"Nazif","year":"2017","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.ghir.2020.101317_bb0200","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bone.2017.07.009","article-title":"Impaired bone strength estimates at the distal tibia and its determinants in adolescents with anorexia nervosa","volume":"106","author":"Singhal","year":"2018","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.ghir.2020.101317_bb0205","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1210\/jc.2012-4153","article-title":"Adolescent girls with anorexia nervosa have impaired cortical and trabecular microarchitecture and lower estimated bone strength at the distal radius","volume":"98","author":"Faje","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ghir.2020.101317_bb0210","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bone.2007.07.017","article-title":"Does weight gain induce cortical and trabecular bone regain in anorexia nervosa? A two-year prospective study","volume":"41","author":"Milos","year":"2007","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.ghir.2020.101317_bb0215","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00198-004-1759-2","article-title":"Cortical and trabecular bone density and structure in anorexia nervosa","volume":"16","author":"Milos","year":"2005","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.ghir.2020.101317_bb0220","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.bone.2009.09.005","article-title":"Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa","volume":"46","author":"Lawson","year":"2010","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.ghir.2020.101317_bb0225","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00223-017-0254-7","article-title":"The role of body weight on bone in anorexia nervosa: a HR-pQCT study","volume":"101","author":"Frolich","year":"2017","journal-title":"Calcif. Tissue Int."},{"issue":"12","key":"10.1016\/j.ghir.2020.101317_bb0230","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1210\/jc.2014-2104","article-title":"Comparison of hip geometry, strength, and estimated fracture risk in women with anorexia nervosa and overweight\/obese women","volume":"99","author":"Bachmann","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2020.101317_bb0235","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1148\/radiol.2016160970","article-title":"Anorexia nervosa: analysis of trabecular texture with CT","volume":"283","author":"Tabari","year":"2017","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.ghir.2020.101317_bb0240","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/eat.22248","article-title":"Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa","volume":"47","author":"Faje","year":"2014","journal-title":"Int J Eat Disord"},{"issue":"3","key":"10.1016\/j.ghir.2020.101317_bb0245","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/eat.10101","article-title":"Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders--a nationwide register study","volume":"32","author":"Vestergaard","year":"2002","journal-title":"Int J Eat Disord"},{"issue":"12","key":"10.1016\/j.ghir.2020.101317_bb0250","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1210\/jc.2003-030532","article-title":"Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism","volume":"88","author":"Misra","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2020.101317_bb0255","first-page":"2056","article-title":"Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis","volume":"84","author":"Stoving","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.ghir.2020.101317_bb0260","first-page":"2084","article-title":"Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation","volume":"82","author":"Argente","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.ghir.2020.101317_bb0265","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1210\/jcem.82.10.4275","article-title":"Spontaneous nocturnal growth hormone secretion in anorexia nervosa","volume":"82","author":"Scacchi","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2020.101317_bb0270","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1210\/jc.2003-031861","article-title":"Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls","volume":"89","author":"Misra","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ghir.2020.101317_bb0275","first-page":"762","article-title":"The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins","volume":"75","author":"Counts","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2020.101317_bb0280","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/jc.2009-1730","article-title":"Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa","volume":"95","author":"Fazeli","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2020.101317_bb0285","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jc.2009-1152","article-title":"Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa","volume":"95","author":"Fazeli","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2020.101317_bb0290","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1210\/jc.2008-2532","article-title":"Increased bone marrow fat in anorexia nervosa","volume":"94","author":"Bredella","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2020.101317_bb0295","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/oby.2010.106","article-title":"Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women","volume":"19","author":"Bredella","year":"2011","journal-title":"Obesity (Silver Spring)"},{"issue":"11","key":"10.1016\/j.ghir.2020.101317_bb0300","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1210\/jc.2010-0493","article-title":"Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study","volume":"95","author":"Fazeli","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ghir.2020.101317_bb0305","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1210\/jc.2004-2041","article-title":"Hormonal determinants of regional body composition in adolescent girls with anorexia nervosa and controls","volume":"90","author":"Misra","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.ghir.2020.101317_bb0310","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1530\/EC-17-0200","article-title":"Can growth hormone treatment improve growth in children with severe growth failure due to anorexia nervosa? A preliminary pilot study","volume":"6","author":"Leger","year":"2017","journal-title":"Endocr Connect"},{"issue":"11","key":"10.1016\/j.ghir.2020.101317_bb0315","first-page":"3864","article-title":"Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa","volume":"81","author":"Grinspoon","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ghir.2020.101317_bb0320","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bone.2009.06.002","article-title":"Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa","volume":"45","author":"Misra","year":"2009","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.ghir.2020.101317_bb0325","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1210\/jcem.87.6.8574","article-title":"Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa","volume":"87","author":"Grinspoon","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ghir.2020.101317_bb0330","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1210\/jc.2002-021402","article-title":"Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: a randomized-controlled study","volume":"88","author":"Grinspoon","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637420300265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637420300265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:51:40Z","timestamp":1761087100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637420300265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":66,"alternative-id":["S1096637420300265"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2020.101317","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential applications for rhIGF-I: Bone disease and IGFI","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2020.101317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101317"}}